Singapore markets closed

Sino Biopharmaceutical Limited (1177.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
4.720+0.220 (+4.89%)
At close: 04:08PM HKT
Show:
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
26,861,356
26,861,356
23,647,224
24,234,030
20,888,584
Cost of revenue
5,332,095
5,332,095
5,182,320
4,926,268
4,196,932
Gross profit
21,529,261
21,529,261
18,464,904
19,307,762
16,691,652
Operating expenses
Research development
-
-
2,626,709
2,398,712
2,090,567
Selling general and administrative
12,703,627
12,703,627
11,628,561
11,908,760
10,268,045
Total operating expenses
17,185,822
17,185,822
14,160,755
14,216,510
12,372,176
Operating income or loss
4,343,439
4,343,439
4,304,149
5,091,252
4,319,476
Interest expense
308,617
308,617
323,368
229,950
153,264
Income before tax
18,572,673
18,572,673
5,013,044
5,583,822
11,429,081
Income tax expense
1,957,880
1,957,880
672,377
889,448
696,236
Income from continuing operations
16,614,793
16,614,793
4,340,667
4,694,374
10,732,845
Net income
14,608,412
14,608,412
2,771,086
2,706,794
9,046,347
Net income available to common shareholders
14,608,412
14,608,412
2,771,086
2,706,794
9,046,347
Basic EPS
-
-
0.15
0.14
0.49
Diluted EPS
-
-
0.15
0.14
0.49
Basic average shares
-
-
18,800,284
18,811,056
18,548,557
Diluted average shares
-
-
18,800,284
18,811,056
18,548,557
EBITDA
-
19,873,846
6,991,248
7,279,800
12,758,469